These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Comparative effects of oncogenic mutations G12C, G12V, G13D, and Q61H on local conformations and dynamics of K-Ras. Vatansever S; Erman B; Gümüş ZH Comput Struct Biotechnol J; 2020; 18():1000-1011. PubMed ID: 32373288 [TBL] [Abstract][Full Text] [Related]
30. Binding of Inhibitors to BACE1 Affected by pH-Dependent Protonation: An Exploration from Multiple Replica Gaussian Accelerated Molecular Dynamics and MM-GBSA Calculations. Chen J; Zhang S; Wang W; Sun H; Zhang Q; Liu X ACS Chem Neurosci; 2021 Jul; 12(14):2591-2607. PubMed ID: 34185514 [TBL] [Abstract][Full Text] [Related]
31. Cobimetinib Plus Gemcitabine: An Active Combination in KRAS G12R-Mutated Pancreatic Ductal Adenocarcinoma Patients in Previously Treated and Failed Multiple Chemotherapies. Ardalan B; Azqueta J; Sleeman D J Pancreat Cancer; 2021; 7(1):65-70. PubMed ID: 34901697 [No Abstract] [Full Text] [Related]
32. Exploring KRas Protein Dynamics: An Integrated Molecular Dynamics Analysis of KRas Wild and Mutant Variants. Mir SA; Nayak B; Aljarba NH; Kumarasamy V; Subramaniyan V; Dhara B ACS Omega; 2024 Jul; 9(28):30665-30674. PubMed ID: 39035919 [TBL] [Abstract][Full Text] [Related]
33. Gaussian Accelerated Molecular Dynamics in NAMD. Pang YT; Miao Y; Wang Y; McCammon JA J Chem Theory Comput; 2017 Jan; 13(1):9-19. PubMed ID: 28034310 [TBL] [Abstract][Full Text] [Related]
34. KRAS Switch Mutants D33E and A59G Crystallize in the State 1 Conformation. Lu J; Bera AK; Gondi S; Westover KD Biochemistry; 2018 Jan; 57(3):324-333. PubMed ID: 29235861 [TBL] [Abstract][Full Text] [Related]
35. Virtual Screening Based on Machine Learning Explores Mangrove Natural Products as KRAS Luo L; Zheng T; Wang Q; Liao Y; Zheng X; Zhong A; Huang Z; Luo H Pharmaceuticals (Basel); 2022 May; 15(5):. PubMed ID: 35631410 [TBL] [Abstract][Full Text] [Related]
36. Discovery of ARS-1620 analogs as KRas G12C inhibitors with high in vivo antitumor activity. Zhao H; Li L; Liu J; Mai R; Chen J; Chen J Bioorg Chem; 2022 Apr; 121():105652. PubMed ID: 35158284 [TBL] [Abstract][Full Text] [Related]
37. Mutational landscape of K-Ras substitutions at 12th position-a systematic molecular dynamics approach. S UK; R B; D TK; Doss CGP; Zayed H J Biomol Struct Dyn; 2022 Mar; 40(4):1571-1585. PubMed ID: 33034275 [TBL] [Abstract][Full Text] [Related]
38. KRAS allel-specific activity of sunitinib in an isogenic disease model of colorectal cancer. Modest DP; Camaj P; Heinemann V; Schwarz B; Jung A; Laubender RP; Gamba S; Haertl C; Stintzing S; Primo S; Bruns CJ J Cancer Res Clin Oncol; 2013 Jun; 139(6):953-61. PubMed ID: 23455880 [TBL] [Abstract][Full Text] [Related]